Joah Sundrani, PharmD, MBA, BCSCP, FACA, serves as Vice President of Compliance and Compounding
Innovation at SandsRx, a 503A sterile and nonsterile compounding pharmacy with multiple locations in
North Texas. In this role, Joah oversees regulatory compliance, quality systems, sterile compounding
operations, and vendor qualification, and works closely with marketing and sales teams to ensure
compliant, effective communications. Joah is an active member of the APhA Compounding Community and
serves on the APhA advisory committee for the BCSCP recertification course, supporting continued
board certification for sterile compounding pharmacists. Joah has presented nationally on quality
and compliance topics, including CAPA case studies at NHIA 2026, and moderated a USP 795, 797, and
800 panel at the Compounding Compliance Conference. At the state and local levels, Joah serves as a
director of the Texas Pharmacy Association, where Joah has contributed to regulatory comments on
federal compounding actions, and is a past president of the Dallas Area Pharmacy Association. As
DAPA's digital and social media chair for several years, Joah developed a strong foundation in
advocacy communications, graphic design, and targeted outreach. Joah is also a dedicated preceptor
committed to educating the next generation of compounding pharmacists. Joah believes the art of
compounding must be protected and advanced through engagement, visibility, and education, and is
honored to be considered for Community leadership.